GALAD Demonstrates High Sensitivity for HCC Surveillance in a Cohort of Patients with Cirrhosis. Singal AG, Nabihah T, Mehta A, Marrero JA, et al. Hepatology 2021 Oct 7. doi: 10.1002/hep.32185.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Singal AG, Nabihah T, Mehta A, Marrero JA, et al. GALAD Demonstrates High Sensitivity for HCC Surveillance in a Cohort of Patients with Cirrhosis. Hepatology 2021 Oct 7. doi: 10.1002/hep.32185.
PMID: 34618932